• 1
    Bailar, J.C. & Mosteller, F. (1992) Medical Uses of Statistics, pp. 247 250. NEJM Books, Boston.
  • 2
    Beck, J., Niethammer, D., Gekeler, V. (1994) High mdr1 and mrp, but low topoisomerase 11 alpha-gene expression in B-cell chronic lymphocytic leukaemias. Cancer Letters, 86, 135 142.
  • 3
    Beck, W., Muellar, T., Tanzer, L. (1979) Altered surface membrane glycoproteins in vincristine alkaloids-resistant human leukaemic lymphoblasts. Cancer Research, 39, 2070 2076.
  • 4
    Burger, H., Nooter, K., Sonneveld, P., Van Wingerden, K.E., Zaman, G.J.R., Stoter, G. (1994) High expression of the multidrug resistance-associated protein (MRP) in chronic and prolymphocytic leukaemia. British Journal of Haematology, 88, 348 356.
  • 5
    Cole, S., Bhardwaj, G., Gerlach, J., Mackie, J., Grant, C., Almquist, K., Stewart, A., Kurz, E., Duncan, A., Deeley, R. (1992) Overexpression of a transporter gene in a multidrug resistant human lung cancer cell line. Science, 258, 1650 1654.
  • 6
    Grant, C.E., Valdimarsson, G., Hipfner, D.R., Almquist, K.C., Cole, S.P.C., Deeley, R.G. (1994) Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Research, 54, 357 361.
  • 7
    Gros, P., Ben Neriah, Y., Croop, J.M., Housman, D.E. (1986) Isolation and expression of a cDNA (mdr) that confers multidrug resistance. Nature, 323, 728 731.
  • 8
    Hipfner, D.R., Gauldie, S.D., Deeley, R.G., Cole, S.P. (1994) Detection of M(r) 190,000 multidrug resistance, MRP with monoclonal antibodies. Cancer Research, 54, 5788 5792.
  • 9
    Holmes, J.A., Jacobs, A., Carter, G., Whittaker, J.A., Bentley, D.P., Padua, R.A. (1990) Is the mdr 1 gene relevant in chronic lymphocytic leukemia? Leukemia, 4, 216 218.
  • 10
    Islam, D., Lindberg, A., Christensson, B. (1995) Peripheral blood cell preparation influences the level of expression of leukocyte cell surface markers as assessed with quantitative multicolor flow cytometry. Cytometry, 22, 128 34.
  • 11
    Ludescher, C., Hilbe, W., Eisterer, W., Preuss, E., Huber, C., Gotwald, M., Hofman, J., Thaler, J. (1993) Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometry assay. Journal of the National Cancer Institute, 85, 1751 1758.
  • 12
    Michieli, M., Raspadori, D., Damiani, D., Geromin, A., Gallizia, C., Michelutti, A., Fanin, R., Fasola, G., Russo, D., Tazzari, P., Pileri, S., Mallardi, F., Baccarani, M. (1991) The expression of the multidrug resistance-associated glycoprotein in B-cell chronic lymphocytic leukaemia. British Journal of Haematology, 77, 460 465.
  • 13
    Peters, R., Janossy, G., Ivory, K., al-Ismail, S., Mercolino, T. (1996) Leukemia-associated changes identified by quantitative flow cytometry: B-cell gating in CD37/kappa/lambda clonality test. Leukemia, 8, 1864 70.
  • 14
    Ribrag, V., Massade, L., Faussat, A.M., Dreyfus, F., Bayle, C., Gouyette, A., Marie, J.P. (1996) Drug resistance mechanisms in chronic lymphocytic leukemia. Leukemia, 10, 1944 1949.
  • 15
    Shustik, C., Groulx, N., Gros, P. (1991) Analysis of multidrug resistance (MDR-1) gene expression in chronic lymphocytic leukaemia (CLL). British Journal of Haematology, 79, 50 56.
  • 16
    Sonneveld, P., Nooter, K., Burghouts, J.Th.M., Herweijer, H., Adriaansen, H.J., Van Dongen, J.J.M. (1992) High expression of the mdr3 multidrug-resistance gene in advanced-stage chronic lymphocytic leukemia. Blood, 79, 1496 1500.
  • 17
    Sparrow, R.L., Hall, F.J., Siregar, H., Van der Weyden, M.B. (1993) Common expression of the multidrug resistance marker P-glycoprotein in B-cell chronic lymphoproliferative leukemia and correlation with in vitro drug resistance. Leukemia Research, 17, 941 947.
  • 18
    Ueda, K., Cornwell, M.M., Gottesman, M.M., Pastan, I., Roninson, I.B., Ling, V., Riordan, J.R. (1986) The mdr1 gene, responsible for multidrug resistance, codes for P-glycoprotein. Biochemical and Biophysical Research Communications, 141, 956 962.
  • 19
    Wallner, J., Gisslinger, H., Gisslinger, B., Gsur, A., Gotzl, M., Zochbauer, S., Pirker, R. (1994) MDR1 gene expression in chronic lymphocytic leukaemia. Leukaemia and Lymphoma, 13, 333 338.
  • 20
    Webb, M., Raphael, C., Asbahr, H., Erber, W.N., Meyer, B. (1996) The detection of rhodamine 123 efflux at low levels of drug resistance. British Journal of Haematology, 93, 650 655.
  • 21
    Wulf, G., Kluding, H., Ho, A.D., Doerner, M., Doehner, H., Manegold, C., & Hunstein, W. (1994) Multidrug resistance phenotype in patients with chronic lymphocytic leukemia as detected by immunofluorescence (FACS) and Northern blot analysis. Leukemia Research, 18, 475 484.
  • 22
    Zaman, G.J.R., Flens, M.J., Van Leusden, M.R., de Hass, M., Mulder, H.S., Lankelma, J., Pinedo, H.M., Scheper, R.J., Baas, F., Broxterman, H.J., Borst, P. (1994) The human multidrug resistance-associated protein (MRP) is a plasma membrane drug efflux pump. Proceedings of the National Academy of Sciences of the United States of America, 91, 8822 8826.